|3.97||-0.095 / -2.34%|
As of 3:59pm ET
|3.97||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +76.32% increase from the last price of 3.97.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.